CytoSorbents: 2Q Earnings Snapshot
Posted August 4, 2020 5:43 pm.
Last Updated August 4, 2020 5:54 pm.
This article is more than 5 years old.
MONMOUTH JUNCTION, N.J. (AP) _ CytoSorbents Corp. (CTSO) on Tuesday reported a loss of $2.9 million in its second quarter.
The Monmouth Junction, New Jersey-based company said it had a loss of 8 cents per share.
The results met Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for a loss of 8 cents per share.
The blood purification therapy company posted revenue of $9.8 million in the period, which also matched Street forecasts.
CytoSorbents shares have more than doubled since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $9.41, a climb of 43% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CTSO at https://www.zacks.com/ap/CTSO
The Associated Press
